Stroke is a common disease affecting over 700,000 people in the US each year. It is the 3rd leading cause of death and a leading cause of long term disability. Most strokes are ischemic (85%). Hemorrhagic events make up the remainder and are divided into intracerebral hemorrhage and subarachnoid hemorrhage. The modern management of stroke focuses on acute treatment and prevention. This review will focus on three areas - the general medical management of acute ischemic stroke, thrombolytic therapy for acute ischemic stroke, and secondary prevention of stroke in patients with ischemic stroke or transient ischemic attack (TIA).curriculum_fellow; VBsecondarypreventio
This article provides a practical overview of current medical treatments for acute ischaemic stroke,...
Cerebrovascular disease is the third leading cause of mortality and the leading cause of long-term n...
This article provides a practical overview of current medical treatments for acute ischaemic stroke,...
Cerebrovascular disease can be devastating for patients and their families. However, there is much t...
Cerebrovascular disease can be devastating for patients and their families. However, there is much t...
Cerebrovascular disease can be devastating for patients and their families. However, there is much t...
WOS: 000248665300005PubMed: 17630934Approximately 5.7 million people died from stroke in 2005 [1]. A...
Stroke is a major contributor to death and disability worldwide. Prior to modern therapy, post-strok...
The statistics for stroke in the USA reads like a familiar ad slogan cited in most papers pertaining...
Background: Stroke is a global burden and leading cause of death. Stroke is considered as third lead...
Each year in the US, approximately 600 000 people willexperience an ischemic stroke. Of those people...
Stroke is the second most common cause of death and major cause of disability worldwide. Because of ...
persons have a stroke; in 200,000 of these patients, the strokes are recurrent.1 Of the 500,000 pati...
OBJECTIVE To help family physicians who care for patients with acute stroke or who are involved in p...
This article provides a practical overview of current medical treatments for acute ischaemic stroke,...
This article provides a practical overview of current medical treatments for acute ischaemic stroke,...
Cerebrovascular disease is the third leading cause of mortality and the leading cause of long-term n...
This article provides a practical overview of current medical treatments for acute ischaemic stroke,...
Cerebrovascular disease can be devastating for patients and their families. However, there is much t...
Cerebrovascular disease can be devastating for patients and their families. However, there is much t...
Cerebrovascular disease can be devastating for patients and their families. However, there is much t...
WOS: 000248665300005PubMed: 17630934Approximately 5.7 million people died from stroke in 2005 [1]. A...
Stroke is a major contributor to death and disability worldwide. Prior to modern therapy, post-strok...
The statistics for stroke in the USA reads like a familiar ad slogan cited in most papers pertaining...
Background: Stroke is a global burden and leading cause of death. Stroke is considered as third lead...
Each year in the US, approximately 600 000 people willexperience an ischemic stroke. Of those people...
Stroke is the second most common cause of death and major cause of disability worldwide. Because of ...
persons have a stroke; in 200,000 of these patients, the strokes are recurrent.1 Of the 500,000 pati...
OBJECTIVE To help family physicians who care for patients with acute stroke or who are involved in p...
This article provides a practical overview of current medical treatments for acute ischaemic stroke,...
This article provides a practical overview of current medical treatments for acute ischaemic stroke,...
Cerebrovascular disease is the third leading cause of mortality and the leading cause of long-term n...
This article provides a practical overview of current medical treatments for acute ischaemic stroke,...